Related references
Note: Only part of the references are listed.Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
Tadech Boonpiyathad et al.
FRONTIERS IN ALLERGY (2021)
Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy
Azahara Rodriguez-Dominguez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
EAACI Allergen Immunotherapy User's Guide
Montserrat Alvaro-Lozano et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
CRM197-Coupled Der p 2 Peptides Suppress Allergic Airway Inflammation in a Der p 2-Induced Asthma Mouse Model
Cong Wang et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
A Fusion Protein of Derp2 Allergen and Flagellin Suppresses Experimental Allergic Asthma
Wenzhi Tan et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)
Construction of a recombinant B-cell epitope vaccine based on a Der p1-derived hypoallergen: a bioinformatics approach
Songwe Fanuel et al.
IMMUNOTHERAPY (2018)
Home Environmental Interventions for House Dust Mite
Jeffrey M. Wilson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Allergen Immunotherapy History and Future Developments
Giovanni Passalacqua et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2016)
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
Rudolf Valenta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Prevention of allergic asthma through Der p 2 peptide vaccination
Gregory Bouchaud et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
Margarete Focke-Tejkl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
Ruth E. Soria-Guerra et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2015)
House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies
Moises A. Calderon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
Conversion of Der p 23, a New Major House Dust Mite Allergen, into a Hypoallergenic Vaccine
Srinita Banerjee et al.
JOURNAL OF IMMUNOLOGY (2014)
Recombinant house dust mite allergens
Susanne Vrtala et al.
METHODS (2014)
T-cell epitope vaccine design by immunoinformatics
Atanas Patronov et al.
OPEN BIOLOGY (2013)
Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy
Kuan-Wei Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Asthma phenotypes: the evolution from clinical to molecular approaches
Sally E. Wenzel
NATURE MEDICINE (2012)
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS
Katarzyna Niespodziana et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Recombinant allergens for specific immunotherapy
Oliver Cromwell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity
M. Focke et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
A Combination Vaccine for Allergy and Rhinovirus Infections Based on Rhinovirus-Derived Surface Protein VP1 and a Nonallergenic Peptide of the Major Timothy Grass Pollen Allergen Phl p 1
Johanna Edlmayr et al.
JOURNAL OF IMMUNOLOGY (2009)
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering
Kuan-Wei Chen et al.
MOLECULAR IMMUNOLOGY (2008)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Share Paper
